Incyte Shares Rise on EPS Growth, Lifted Guidance, Expansion

It's no wonder INCY shares are up 15% this year, and they could rise more. MoneyFlows data shows how Big Money investors are ...
The American Journal of Managed Care

SYNC-T: Immunotherapy Platform Brings 4-Part Attack in Prostate Cancer, With More Trials Planned

Development is moving to phase 2 LEGION-100-2a (NCT06533644) across global sites, with planned neoadjuvant prostate studies and expansion concepts in multiple solid tumors. Metastatic ...
RMD Open

Prevalence of sarcopenia in patients with rheumatoid arthritis: a cross-sectional study

Objective Sarcopenia, defined by reductions in muscle mass and strength, increases the risk of adverse outcomes in patients with rheumatoid arthritis (RA)—driven in part by chronic inflammation—and is ...
RMD Open

Rare variants in genes related to inborn errors of immunity in patients with rheumatoid arthritis and secondary immunodeficiency

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...
Opinion
en.araOpinion

Why science has failed women (and how we can change it right now)

Reducing medicine to a single universal model has harmed women, but has also made science less complete and medicine less precise ...